Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04420143 · ClinicalTrials.gov registry record
MLX/XLX ACR Expandable Lumbar Interbody Implants
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 109
- Enrollment target
NCT04420143 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 109 participants.
The verdict
NCT04420143 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and performance of thoracic and/or lumbar spine surgery using the MLX and XLX ACR interbody implants as measured by reported complications, radiographic outcomes, and clinical patient outcomes. This study is being undertaken to identify possible residual risks and to clarify mid- to long-term clinical performance that may affect the benefit/risk ratios of the MLX and XLX ACR interbody implants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2020-01-27 |
| Est. Completion | 2020-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04420143
The ClinicalTrials.gov registry entry for NCT04420143 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04420143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04420143 about?
NCT04420143 is a clinical study titled "MLX/XLX ACR Expandable Lumbar Interbody Implants". The objective of this study is to evaluate the safety and performance of thoracic and/or lumbar spine surgery using the MLX and XLX ACR interbody implants as measured by reported complications, radiographic outcomes, and clinical patient outcomes. This study is being undertaken to identify possible ...
What is the current status of trial NCT04420143?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2020-01-27. Estimated completion is 2020-10-23.
Who is sponsoring clinical trial NCT04420143?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.